Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcomes of Legal Abortion with Feticide Using Intracardiac Potassium Chloride Injection
IRCT20231028059887N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of potassium chloride in abortion, sponsored by Tehran University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
potassium chloride
03
Conditions
abortion
Beyond the preview
Go deeper on IRCT20231028059887N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231028059887N2.